Page 3 - Clinician Brief Summary Instructions News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Clinician brief summary instructions. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Clinician Brief Summary Instructions Today - Breaking & Trending Today

Pear Therapeutics Announces Second Closing of Series D Financing

Company adds a leading national Integrated Delivery Network (IDN) as a strategic investor.
The financing supports Pear’s continued efforts to expand patient access for its portfolio of Prescription Digital Therapeutics (PDTs), including reSET®, reSET-O® and Somryst® treating addiction and insomnia conditions, respectively.
BOSTON & SAN FRANCISCO–(BUSINESS WIRE)–Pear Therapeutics, Inc., (“Pear” or the “Company”) today announced the second closing of its Series D financing. The second closing included a leading national Integrated Delivery Network (IDN) as a new strategic investor. The national IDN is investing $20 million, bringing the total Series D investment to $100 million.
“Pear is pleased to add one of America’s leading health care providers and health plans to our distinguished list of investors as we continue to expand patient access to our FDA-authorized digital therapeutics,” said Corey McCann, M.D., Ph.D., President and CEO of Pear Ther ....

United States , Keely Boyer , Ba Fulton Velez , Karren Williams , Robert Gerwien , Weijia Wang , Yuria Maricich , Charles Ruetsch Kathryn Anastassopoulos , Bruce Imbert , Laura Kauffman , Xiaorui Xiong , Corey Mccann , Stephen Braun , Hilaryf Luderer , Sam Colman , Alice Kuo , Nicole Gellings Lowe , Fultonf Velez , Health Care Provider , Journal Of Current Medical Research , Mental Health Services Administration , Expert Review Of Pharmacoeconomics Outcomes Research , Pear Therapeutics Inc , Delivery Network , Software Precertification Pilot Program , Integrated Delivery Network ,

Pear Therapeutics Announces Publication of Economic Analysis Showing Cost-Effectiveness of reSET-O® in Treating Opioid Use Disorder

Pear Therapeutics Announces Publication of Economic Analysis Showing Cost-Effectiveness of reSET-O® in Treating Opioid Use Disorder
digitalmedianet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from digitalmedianet.com Daily Mail and Mail on Sunday newspapers.

United States , Keely Boyer , Karren Williams , Ba Fulton Velez , Robert Gerwien , Weijia Wang , Warrenk Bickel , Kirstin Gatchalian , Yuria Maricich , Charles Ruetsch Kathryn Anastassopoulos , Bruce Imbert , Laura Kauffman , Xiaorui Xiong , Stephen Braun , Lisaa Marsch , Yuri Maricich , Hilaryf Luderer , Sam Colman , Fultonf Velez , Nicole Gellings Lowe , Alice Kuo , Journal Of Current Medical Research , Mental Health Services Administration , Expert Review Of Pharmacoeconomics Outcomes Research , Software Precertification Pilot Program , National Survey On Drug ,

Groups Recover Together Teams with Pear Therapeutics to Provide People in Recovery Access to Innovative Treatment

News Category Global Banking & Finance Reviews
Groups Recover Together Teams with Pear Therapeutics to Provide People in Recovery Access to Innovative Treatment
Groups Recover Together Teams with Pear Therapeutics to Provide People in Recovery Access to Innovative Treatment
Opioid use disorder (OUD) is often an isolating experience and with COVID-19-related social distancing, fostering recovery is challenging. Recover Together, Inc. (Groups), a leading outpatient treatment provider serving individuals with OUD across eight states, and Pear Therapeutics, Inc., the leader in prescription digital therapeutics (PDTs), today announced a combined effort to treat OUD patients by providing them with Pears innovative technology as well as Groups innovative approach to treatment. ....

United States , Keely Boyer , Ba Fulton Velez , Karren Williams , Robert Gerwien , Weijia Wang , Meara Murphy , Yuria Maricich , Charles Ruetsch Kathryn Anastassopoulos , Bruce Imbert , Laura Kauffman , Xiaorui Xiong , Julia Strandberg , Hilaryf Luderer , Stephen Braun , Sam Colman , Nicole Gellings Lowe , Fultonf Velez , Alice Kuo , Journal Of Current Medical Research , Expert Review Of Pharmacoeconomics Outcomes Research , Corporate Communications , Pear Therapeutics Inc , Fdas Software Precertification Pilot Program , Pear Therapeutics , Stephanie Stitt ,

Pear Therapeutics Announces Publication of Economic Analysis Assessing the Cost-Effectiveness of reSET-O® in Treating Opioid Use Disorder (OUD) |

Pear Therapeutics Announces Publication of Economic Analysis Assessing the Cost-Effectiveness of reSET-O® in Treating Opioid Use Disorder (OUD)
By
Staff
4 months ago
reSET-O® is the first and only FDA-authorized Prescription Digital Therapeutic (PDT) for patients with opioid use disorder (OUD).
New economic analysis showed reSET-O to be cost-effective compared to treatment-as-usual alone over 12 weeks, and to have economic dominance when contingency management (CM) was included as part of treatment as usual.
BOSTON & SAN FRANCISCO–(BUSINESS WIRE)–Pear Therapeutics, Inc., today announced publication of a new economic analysis describing the cost-effectiveness of reSET-O®, the first and only FDA-authorized Prescription Digital Therapeutic (PDT) for the treatment of opioid use disorder (OUD). The analysis, “ ....

United States , Corey Mccann , Keely Boyer , Hilaryf Luderer , Ba Fulton Velez , Stephen Braun , Karren Williams , Robert Gerwien , Sam Colman , Yuria Maricich , Charles Ruetsch Kathryn Anastassopoulos , Bruce Imbert , Laura Kauffman , Xiaorui Xiong , Fultonf Velez , Alice Kuo , Journal Of Current Medical Research , Council Of Economic Advisers , Expert Review Of Pharmacoeconomics Outcomes Research , Pear Therapeutics Inc , Food Drug Administration , Software Precertification Pilot Program , Prescription Digital Therapeutic , Pear Therapeutics , Medical Economics , Opioid Use Disorder ,